Hematological presentation in systemic lupus erythematosus and its relationship with disease activity

References

• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271–1277.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630–640.
   Google Scholar
• Nossent JC. Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients. Semin Arthritis Rheum 1993;23:16–21.
   PubMed Web of Science ®Google Scholar
• Lim MK, Lee CK, Ju YS, Cho YS, Lee MS, Yoo B, Moon HB. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus. Rheumatol Int 2001;20:89–93.
   Google Scholar
• Alarcon-Segovia D. Clinical manifestations of the antipho-spholipid syndrome. J Rheumatol 1992;19:1778–1781.
   PubMed Web of Science ®Google Scholar
• Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. QJM 1991;80:605–612.
   PubMed Web of Science ®Google Scholar
• Keeling DM, Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev 1993;7:199–207.
   PubMed Web of Science ®Google Scholar
• Liu H, Ozaki K, Matsuzaki Y, Abe M, Kosaka M, Saito S. Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1995;100:480–485.
   PubMed Web of Science ®Google Scholar
• Voulgarelis M, Kokori SI, Ioannidis JP, Tzioufas AG, Kyriaki D, Moutsopoulos HM. Anaemia in systemic lupus erythema-tosus: Aetiological profile and the role of erythropoietin. Ann Rheum Dis 2000;59:217–222.
   PubMed Web of Science ®Google Scholar
• Kokori SI, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 2000;108:198–204.
   Google Scholar
• Budman DR, Steinberg AD. Hematologic aspects of systemic lupus erythematosus. Current concepts. Ann Intern Med 1977;86:220–229.
   PubMed Web of Science ®Google Scholar
• Rivero SJ, Diaz-Jouanen E, Alarcon-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 1978;21:295–305.
   PubMed Web of Science ®Google Scholar
• Ames PR, Alves J, Pap AF, Ramos P, Khamashta MA, Hughes GR. Fibrinogen in systemic lupus erythematosus: More than an acute phase reactant? J Rheumatol 2000;27:1190–1195.
   PubMed Web of Science ®Google Scholar
• Patel P, Werth V. Cutaneous lupus erythematosus: A review. Dermatol Clin 2002;20:373–385.
   PubMed Web of Science ®Google Scholar
• Gilliam JN, Sontheimer RD. Skin manifestations of SLE. Clin Rheum Dis 1982;8:207–218.
   PubMedGoogle Scholar
• Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthritis Rheum 1991;21: 55–64.
   PubMed Web of Science ®Google Scholar
• Petri M. Dermatologic lupus: Hopkins Lupus Cohort. Semin Cutan Med Surg 1998;17:219–227.
   PubMed Web of Science ®Google Scholar
• Callen JP. Management of skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol 2002;16: 245–264.
   PubMed Web of Science ®Google Scholar
• Wysenbeek AJ, Leibovici L, Amit M, Weinberger A. Alopecia in systemic lupus erythematosus. Relation to disease manifes-tations. J Rheumatol 1991;18:1185–1186.
   Google Scholar
• Urman JD, Lowenstein MB, Abeles M, Weinstein A. Oral mucosal ulceration in systemic lupus erythematosus. Arthritis Rheum 1978;21:58–61.
   PubMed Web of Science ®Google Scholar
• Jonsson R, Heyden G, Westberg NG, Nyberg G. Oral mucosal lesions in systemic lupus erythematosus—a clinical, histo-pathological and immunopathological study. J Rheumatol 1984;11:38–42.
   PubMed Web of Science ®Google Scholar
• Pennebaker JB, Gilliam JN, Ziff M. Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus. J Clin Invest 197760:1331–1338.
   PubMed Web of Science ®Google Scholar
• Cronin ME. Musculoskeletal manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1988;14:99–116.
   PubMed Web of Science ®Google Scholar
• van Vugt RN1, Derksen RH, Kater L, Bijlsma JW Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus. Ann Rheum Dis 1998;57:540–544.
   PubMed Web of Science ®Google Scholar
• Franceschini F, Cretti L, Quinzanini M, Rizzini FL, Cattaneo R. Deforming arthropathy of the hands in systemic lupus erythematosus is associated with antibodies to SSA/Ro and to SSB/La. Lupus 1994;3:419–422.
   Google Scholar
• Ostendorf B, Scherer A, Specker C, Modder U, Schneider M. Jaccoud’s arthropathy in systemic lupus erythematosus: Differentiation of deforming and erosive patterns by magnetic resonance imaging. Arthritis Rheum 2003;48:157–165.
   Google Scholar
• Isenber DA, Snaith ML. Muscle Disease in systemic lupus erythematosus: A study of its nature, frequency and cause. J Rheumatol 1981;8:917–924.
   PubMed Web of Science ®Google Scholar
• Kashgarian M. Lupus nephritis: Lessons from the path lab. Kidney Int 1994;45:928–938.
   PubMed Web of Science ®Google Scholar
• Fries JW, Mendrick DL, Rennke HG. Determinants of immune complex-mediated glomerulonephritis. Kidney Int 1988;34:333–345.
   PubMed Web of Science ®Google Scholar
• Hulsey M, Goldstein R, Scully L, Surbeck W, Reichlin M. Anti-ribosomal P antibodies in systemic lupus erythematosus: A case-control study correlating hepatic and renal disease. Clin Immunol Immunopathol 1995;74:252–256.
   Google Scholar
• Ben-Yehuda A, Rasooly L, Bar-Tana R, Breuer G, Tadmor B, Ulmansky R, Naparstek Y. The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J Autoimmun 1995;8:279–291.
   Google Scholar
• Akashi Y, Yoshizawa N. Participation of histones and ubiquitin in lupus nephritis. Nippon Jinzo Gakkai Shi 1995;37: 462–467.
   PubMedGoogle Scholar
• Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: Current concepts and continuing controversies. Arthritis Rheum 1996;39:894–903.
   PubMed Web of Science ®Google Scholar
• Mannik M, Merrill CE, Stamps LD, Wener MH. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 2003;30:1495–1504.
   PubMed Web of Science ®Google Scholar
• Bhandari S, Harnden P, Brownjohn AM, Turney JH. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM 1998; 91:401–409.
   PubMed Web of Science ®Google Scholar
• Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999;74: 275–284.
   Google Scholar
• Sibley JT, Olszynski WP, Decoteau WE, Sundaram MB. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 1992;19:47–52.
   PubMed Web of Science ®Google Scholar
• Wong KL, Woo EK, Yu YL, Wong RW. Neurological manifestations of systemic lupus erythematosus: A prospective study. QJM 1991;81:857–870.
   PubMed Web of Science ®Google Scholar
• Bruyn GA. Controversies in lupus: Nervous system involve-ment. Ann Rheum Dis 1995;54:159–167.
   PubMed Web of Science ®Google Scholar
• Futrell N, Schultz LR, Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology 1992;42:1649–1657.
   Google Scholar
• Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996;348:1120–1124.
   PubMed Web of Science ®Google Scholar